GGrantIndex
Sort

38,696 grants matching als

Cochlear Detoxification System

$469,872
Shinichi Someya · University Of Florida · R01 · FY2015 · DC

Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS

$469,838
Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · NS

Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS

$469,838
Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · NS

Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS

$469,838
Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · NS

Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS

$469,838
Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · NS

Induced Pluripotent Stem Cells and Drosophila Models of C9ORF72-Related FTD/ALS

$469,838
Fen-Biao Gao · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · NS

Health-associated oral bacteria as anti-cancer and immunomodulatory agents in oral cancer

$469,830
Nezar Al-Hebshi · Temple Univ Of The Commonwealth · R21 · FY2024 · DE

Mechanisms of Tumor Cell Dormancy and Tumor Recurrence

$469,647
Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Measuring DNA Damage and Repair Capacity in Human Populations

$469,491
Michele K Evans · National Institute On Aging · ZIA · FY2009 · AG

PATHOGENESIS OF HUMAN GRANULOCYTIC EHRLICHIOSIS

$469,403
University Of Minnesota Twin Cities · R01 · FY2001 · AI

Culture-Based Prediction of Adolescent HIV Risk

$469,335
Stephen L Eyre · University Of California, San Francisco · R01 · FY2010 · HD

Peer Leaders as HIV Risk Reduction Change Agents Among IDUs in Ukraine

$469,329
Robert E Booth · University Of Colorado Denver · R01 · FY2012 · DA

Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer

$469,327
Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2025 · CA

Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)

$469,300
Karen S Marder · Columbia University Health Sciences · U24 · FY2023 · NS

Therapeutics to Prevent/Treat Lassa Fever Virus

$469,250
Scripps Research Institute · R21 · FY2003 · AI

Research Strategy: Multisystemic Study of Early Mathematics Development

$469,199
David C Geary · University Of Missouri-Columbia · P20 · FY2024 · HD

DNA Methylation at N6-Adenine in Placental Trophoblast Development

$469,096
Zongliang Jiang · University Of Florida · R01 · FY2022 · HD

Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma

$469,085
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Molecular Determinants of liver sinusoidal endothelial cells for hepatic regeneration

$469,039
Shahin Rafii · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK

Characterizing accuracy and variability in speech sound productions across bidialectal and bilingual preschoolers

$469,036
Karla N Washington · University Of Toronto · R01 · FY2025 · DC

X-ray Diffraction Analysis of Human Adenovirus

$469,013
Vijay S Reddy · Scripps Research Institute, The · R01 · FY2010 · AI

Dynamics of Kinesins, Dyneins, and Myosins

$468,865
Paul R Selvin · University Of Illinois At Urbana-Champaign · R01 · FY2008 · AR

Role of Peroxisome Proliferation in Leptin Resistance

$468,801
Sabrina Diano · Yale University · R01 · FY2019 · DK

Refining the Diagnosis of Alcohol Use Disorder: A Comprehensive Approach

$468,792
Kenneth J Sher · University Of Missouri-Columbia · R01 · FY2016 · AA

Project 2

$468,782
Michael Benatar · University Of Miami School Of Medicine · U54 · FY2014 · NS